SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001401914-23-000045
Filing Date
2023-08-10
Accepted
2023-08-10 16:01:56
Documents
56
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q dare-20230630.htm   iXBRL 10-Q 825555
2 EX-3.1 ex31_by-laws.htm EX-3.1 225705
3 EX-31.1 exhibit311_20230630.htm EX-31.1 15377
4 EX-31.2 exhibit312_20230630.htm EX-31.2 15133
5 EX-32.1 exhibit321_20230630.htm EX-32.1 4243
6 EX-32.2 exhibit322_20230630.htm EX-32.2 4231
12 dare-20230630_g1.jpg GRAPHIC 130914
  Complete submission text file 0001401914-23-000045.txt   4919530

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT dare-20230630.xsd EX-101.SCH 40609
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT dare-20230630_cal.xml EX-101.CAL 38042
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT dare-20230630_def.xml EX-101.DEF 178392
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT dare-20230630_lab.xml EX-101.LAB 460396
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT dare-20230630_pre.xml EX-101.PRE 284658
50 EXTRACTED XBRL INSTANCE DOCUMENT dare-20230630_htm.xml XML 400574
Mailing Address 3655 NOBEL DRIVE SUITE 260 SAN DIEGO CA 92122
Business Address 3655 NOBEL DRIVE SUITE 260 SAN DIEGO CA 92122 858-926-7655
Dare Bioscience, Inc. (Filer) CIK: 0001401914 (see all company filings)

IRS No.: 204139823 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36395 | Film No.: 231159151
SIC: 2834 Pharmaceutical Preparations